https://www.selleckchem.com/pr....oducts/elamipretide-
391, p less then .001), greater depressive symptoms (β = 0.443, p less then .001), and reduced mobility (β = -0.226, p = .004) (adjusted R2 = 0.613, F = 16.476, p less then .001). Conclusions Children and adolescents with cancer experience multiple, intersecting troubling symptoms during their treatment. There is a need to attend to the biopsychosocial aspects of care for children and adolescents during active cancer treatment. To reduce pediatric oncology patients' fatigue level, clinicians could develop culturally s
Мне нравится
Комментарий
Перепост
